ACAD logo

ACADIA Pharmaceuticals Inc. (ACAD) Cash From Investing

Annual CFI:

-$30.54M-$62.54M(-195.44%)
December 31, 2024

Summary

  • As of today, ACAD annual cash from investing is -$30.54 million, with the most recent change of -$62.54 million (-195.44%) on December 31, 2024.
  • During the last 3 years, ACAD annual cash from investing has risen by +$40.56 million (+57.05%).
  • ACAD annual cash from investing is now -115.86% below its all-time high of $192.51 million, reached on December 31, 2020.

Performance

ACAD Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

Quarterly CFI:

-$43.29M+$80.75M(+65.10%)
June 30, 2025

Summary

  • As of today, ACAD quarterly cash from investing is -$43.29 million, with the most recent change of +$80.75 million (+65.10%) on June 30, 2025.
  • Over the past year, ACAD quarterly cash from investing has increased by +$12.90 million (+22.95%).
  • ACAD quarterly cash from investing is now -122.49% below its all-time high of $192.52 million, reached on March 31, 2023.

Performance

ACAD Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

TTM CFI:

-$127.65M+$12.90M(+9.18%)
June 30, 2025

Summary

  • As of today, ACAD TTM cash from investing is -$127.65 million, with the most recent change of +$12.90 million (+9.18%) on June 30, 2025.
  • Over the past year, ACAD TTM cash from investing has dropped by -$91.18 million (-250.03%).
  • ACAD TTM cash from investing is now -165.87% below its all-time high of $193.78 million, reached on March 31, 2021.

Performance

ACAD TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherACADcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ACAD Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-195.4%+22.9%-250.0%
3Y3 Years+57.0%+22.4%-1283.9%
5Y5 Years+81.6%-134.1%-227.2%

ACAD Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-141.7%+57.0%-122.5%+77.7%-178.5%+26.9%
5Y5-Year-115.9%+81.6%-122.5%+77.7%-165.9%+50.8%
All-TimeAll-Time-115.9%+88.3%-122.5%+79.3%-165.9%+53.5%

ACAD Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$43.29M(+65.1%)
-$127.65M(+9.2%)
Mar 2025
-
-$124.05M(-201.6%)
-$140.55M(-360.2%)
Dec 2024
-$30.54M(-195.4%)
$122.15M(+248.1%)
-$30.54M(+80.0%)
Sep 2024
-
-$82.46M(-46.7%)
-$153.03M(-319.6%)
Jun 2024
-
-$56.19M(-300.3%)
-$36.47M(+79.1%)
Mar 2024
-
-$14.04M(-3945.8%)
-$174.56M(-645.5%)
Dec 2023
$32.00M(-56.3%)
-$347.00K(-101.0%)
$32.00M(+119.2%)
Sep 2023
-
$34.11M(+117.6%)
$14.60M(+458.5%)
Jun 2023
-
-$194.28M(-200.9%)
-$4.07M(-103.0%)
Mar 2023
-
$192.52M(+1184.7%)
$134.41M(+83.5%)
Dec 2022
$73.24M(+203.0%)
-$17.75M(-214.9%)
$73.24M(-54.9%)
Sep 2022
-
$15.44M(+127.7%)
$162.54M(+1862.1%)
Jun 2022
-
-$55.80M(-142.5%)
-$9.22M(-131.4%)
Mar 2022
-
$131.34M(+83.6%)
$29.37M(+141.3%)
Dec 2021
-$71.10M(-136.9%)
$71.55M(+145.8%)
-$71.10M(+72.6%)
Sep 2021
-
-$156.32M(-808.5%)
-$259.61M(-622.3%)
Jun 2021
-
-$17.21M(-155.7%)
$49.71M(-74.3%)
Mar 2021
-
$30.88M(+126.4%)
$193.78M(+0.7%)
Dec 2020
$192.51M(+216.1%)
-$116.96M(-176.4%)
$192.51M(+91.9%)
Sep 2020
-
$152.99M(+20.6%)
$100.32M(+334.7%)
Jun 2020
-
$126.86M(+328.5%)
-$42.75M(+73.1%)
Mar 2020
-
$29.61M(+114.2%)
-$158.99M(+4.1%)
Dec 2019
-$165.84M(-132.0%)
-$209.14M(-2207.7%)
-$165.84M(-13.9%)
Sep 2019
-
$9.92M(-6.6%)
-$145.64M(-17.7%)
Jun 2019
-
$10.63M(-53.3%)
-$123.78M(+10.5%)
Mar 2019
-
$22.76M(+112.0%)
-$138.35M(-93.5%)
Dec 2018
-$71.49M(-177.3%)
-$188.95M(-694.5%)
-$71.49M(-171.9%)
Sep 2018
-
$31.78M(+906.3%)
$99.37M(+14.3%)
Jun 2018
-
-$3.94M(-104.4%)
$86.92M(-32.7%)
Mar 2018
-
$89.62M(+595.3%)
$129.16M(+39.7%)
Dec 2017
$92.47M(+135.3%)
-$18.09M(-193.6%)
$92.47M(-48.5%)
Sep 2017
-
$19.33M(-49.5%)
$179.71M(+3187.7%)
Jun 2017
-
$38.30M(-27.6%)
$5.47M(+113.6%)
Mar 2017
-
$52.94M(-23.4%)
-$40.29M(+84.6%)
Dec 2016
-$261.92M(-277.9%)
$69.14M(+144.6%)
-$261.92M(+4.7%)
Sep 2016
-
-$154.91M(-1976.5%)
-$274.71M(-146.4%)
Jun 2016
-
-$7.46M(+95.6%)
-$111.50M(-85.9%)
Mar 2016
-
-$168.70M(-399.4%)
-$59.97M(-140.7%)
Dec 2015
$147.19M(+268.7%)
$56.35M(+578.3%)
$147.19M(+12.1%)
Sep 2015
-
$8.31M(-81.1%)
$131.32M(-18.9%)
Jun 2015
-
$44.06M(+14.5%)
$161.89M(+221.8%)
Mar 2015
-
$38.47M(-4.9%)
$50.31M(+157.6%)
Dec 2014
-$87.27M
$40.48M(+4.1%)
-$87.27M(+26.2%)
Sep 2014
-
$38.87M(+157.6%)
-$118.21M(+26.6%)
Jun 2014
-
-$67.51M(+31.9%)
-$161.02M(+16.2%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$99.11M(-1138.8%)
-$192.13M(-52.4%)
Dec 2013
-$126.10M(-394.0%)
$9.54M(+342.0%)
-$126.10M(+26.1%)
Sep 2013
-
-$3.94M(+96.0%)
-$170.70M(-0.7%)
Jun 2013
-
-$98.62M(-198.1%)
-$169.50M(-171.2%)
Mar 2013
-
-$33.09M(+5.6%)
-$62.49M(-144.8%)
Dec 2012
-$25.53M(-526.9%)
-$35.05M(-1177.5%)
-$25.53M(-291.3%)
Sep 2012
-
-$2.74M(-132.7%)
$13.34M(-35.1%)
Jun 2012
-
$8.39M(+116.5%)
$20.56M(+10.6%)
Mar 2012
-
$3.88M(+1.6%)
$18.59M(+210.9%)
Dec 2011
$5.98M(+664.2%)
$3.81M(-14.8%)
$5.98M(+206.9%)
Sep 2011
-
$4.48M(-30.3%)
-$5.60M(+21.5%)
Jun 2011
-
$6.42M(+173.5%)
-$7.13M(+56.3%)
Mar 2011
-
-$8.73M(-12.5%)
-$16.31M(-1439.1%)
Dec 2010
-$1.06M(-111.2%)
-$7.76M(-363.7%)
-$1.06M(-107.0%)
Sep 2010
-
$2.94M(+206.6%)
$15.23M(-33.3%)
Jun 2010
-
-$2.76M(-142.4%)
$22.82M(+378.0%)
Mar 2010
-
$6.52M(-23.6%)
$4.77M(-49.5%)
Dec 2009
$9.44M(-86.5%)
$8.53M(-19.0%)
$9.44M(-24.1%)
Sep 2009
-
$10.53M(+150.6%)
$12.45M(-38.0%)
Jun 2009
-
-$20.80M(-285.9%)
$20.09M(-64.3%)
Mar 2009
-
$11.19M(-3.0%)
$56.27M(-19.3%)
Dec 2008
$69.71M(+266.4%)
$11.53M(-36.5%)
$69.71M(+6.7%)
Sep 2008
-
$18.17M(+18.2%)
$65.35M(+48.0%)
Jun 2008
-
$15.38M(-37.6%)
$44.17M(+218.6%)
Mar 2008
-
$24.64M(+243.4%)
-$37.24M(+11.1%)
Dec 2007
-$41.90M(-82.7%)
$7.17M(+337.7%)
-$41.90M(+12.9%)
Sep 2007
-
-$3.02M(+95.4%)
-$48.11M(-5.5%)
Jun 2007
-
-$66.03M(-430.6%)
-$45.62M(-1178.2%)
Mar 2007
-
$19.97M(+1965.3%)
-$3.57M(+84.4%)
Dec 2006
-$22.94M(-244.8%)
$967.00K(+283.1%)
-$22.94M(-27.8%)
Sep 2006
-
-$528.00K(+97.8%)
-$17.95M(-349.6%)
Jun 2006
-
-$23.98M(-4070.0%)
-$3.99M(-27.2%)
Mar 2006
-
$604.00K(-89.8%)
-$3.14M(+52.8%)
Dec 2005
-$6.65M(+9.9%)
$5.95M(-55.7%)
-$6.65M(+47.2%)
Sep 2005
-
$13.43M(+158.1%)
-$12.60M(+51.6%)
Jun 2005
-
-$23.13M(-695.3%)
-$26.03M(-1.2%)
Mar 2005
-
-$2.91M(+87.3%)
-$25.73M(-53.1%)
Dec 2004
-$7.38M(+49.8%)
-
-
Jun 2004
-
-$22.83M(-930.0%)
-$16.81M(-15.2%)
Mar 2004
-
$2.75M(-14.1%)
-$14.59M(+0.7%)
Dec 2003
-$14.69M(-481.7%)
$3.20M(+5006.7%)
-$14.69M(+17.9%)
Sep 2003
-
$62.70K(+100.3%)
-$17.89M(+0.3%)
Jun 2003
-
-$20.60M(-877.7%)
-$17.96M(-777.7%)
Mar 2003
-
$2.65M
$2.65M
Dec 2002
$3.85M(-55.9%)
-
-
Dec 2001
$8.73M
-
-

FAQ

  • What is ACADIA Pharmaceuticals Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. annual cash from investing year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. quarterly cash from investing year-on-year change?
  • What is ACADIA Pharmaceuticals Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for ACADIA Pharmaceuticals Inc.?
  • What is ACADIA Pharmaceuticals Inc. TTM cash from investing year-on-year change?

What is ACADIA Pharmaceuticals Inc. annual cash from investing?

The current annual cash from investing of ACAD is -$30.54M

What is the all-time high annual cash from investing for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high annual cash from investing is $192.51M

What is ACADIA Pharmaceuticals Inc. annual cash from investing year-on-year change?

Over the past year, ACAD annual cash from investing has changed by -$62.54M (-195.44%)

What is ACADIA Pharmaceuticals Inc. quarterly cash from investing?

The current quarterly cash from investing of ACAD is -$43.29M

What is the all-time high quarterly cash from investing for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high quarterly cash from investing is $192.52M

What is ACADIA Pharmaceuticals Inc. quarterly cash from investing year-on-year change?

Over the past year, ACAD quarterly cash from investing has changed by +$12.90M (+22.95%)

What is ACADIA Pharmaceuticals Inc. TTM cash from investing?

The current TTM cash from investing of ACAD is -$127.65M

What is the all-time high TTM cash from investing for ACADIA Pharmaceuticals Inc.?

ACADIA Pharmaceuticals Inc. all-time high TTM cash from investing is $193.78M

What is ACADIA Pharmaceuticals Inc. TTM cash from investing year-on-year change?

Over the past year, ACAD TTM cash from investing has changed by -$91.18M (-250.03%)
On this page